“…There is little doubt that dysregulation of neuronal gene expression in prefrontal cortex (PFC) and other areas of the cerebral cortex regions implicated in the neural circuitry of psychosis (reviewed in Lewis & Sweet, ) contributes to the pathophysiology of SCZ, broadly affecting excitatory and inhibitory neurotransmission, metabolism, myelination, and immune signaling (Arion et al, ; Horvath & Mirnics, ; Middleton, Mirnics, Pierri, Lewis, & Levitt, ; Mirnics, Middleton, Marquez, Lewis, & Levitt, ; Vawter et al, ; Volk et al, ; Zhao et al, ). With the transcriptional process intimately connected to chromatin structure, and function in human cells and model organisms alike (Brown & Celniker, ; Lundberg et al, ), one would therefore expect that epigenomic markers associated with open (“active,” “loose”) chromatin permissive for gene expression, versus repressed, and silenced chromatin, will show significant alterations in brain tissue from subjects diagnosed with SCZ. Such type of epigenomic explorations in SCZ postmortem brain initially focused on DNA methylation, one of the key epigenetic mechanisms involved in the regulation of gene expression (Klose & Bird, ).…”